|
DE60015392D1
(de)
*
|
1999-12-29 |
2004-12-02 |
Glaxo Group Ltd |
Verwendung von annexin-modulatoren zur herstellung eines medikaments zur behandlung und/oder vorbeugung von arthritis und arthritischen erkrankungen
|
|
EP1134221A1
(en)
*
|
2000-03-15 |
2001-09-19 |
Aventis Pharma Deutschland GmbH |
Substituted beta-carbolines as lkB kinase inhibitors
|
|
HUP0300894A3
(en)
*
|
2000-03-15 |
2008-05-28 |
Sanofi Aventis Deutschland |
Substituted beta-carbolines, process for their preparation, pharmaceutical compositions containing them and their use
|
|
US6379900B1
(en)
|
2000-05-09 |
2002-04-30 |
Conceptual Mindworks, Inc. |
Compositions and methods of use of 8-nitroguanine
|
|
US20030045541A1
(en)
*
|
2001-07-23 |
2003-03-06 |
Christopher Bruckner |
GABA-Receptor modulators with NMDA-Antagonistic activity
|
|
WO2006115509A2
(en)
|
2004-06-24 |
2006-11-02 |
Novartis Vaccines And Diagnostics Inc. |
Small molecule immunopotentiators and assays for their detection
|
|
US8119655B2
(en)
*
|
2005-10-07 |
2012-02-21 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
JP2012051804A
(ja)
*
|
2008-12-26 |
2012-03-15 |
Kyoto Univ |
Ｅｇ５阻害剤
|
|
JP5320083B2
(ja)
*
|
2009-01-13 |
2013-10-23 |
坂元醸造株式会社 |
潰瘍性大腸炎治療薬
|
|
US8697662B2
(en)
|
2009-05-27 |
2014-04-15 |
Ptc Therapeutics, Inc. |
Methods for treating Kaposi sarcoma
|
|
MX373926B
(es)
|
2009-05-27 |
2020-07-10 |
Ptc Therapeutics Inc |
Metodos para tratar cancer y estados no neoplasicos.
|
|
WO2010138685A1
(en)
|
2009-05-27 |
2010-12-02 |
Ptc Therapeutics, Inc. |
Methods for treating prostate conditions
|
|
MX2011012517A
(es)
*
|
2009-05-27 |
2012-01-27 |
Ptc Therapeutics Inc |
Procesos para la preparacion de tetrahidro beta - carbolina sustituidas.
|
|
US10703722B2
(en)
|
2010-04-27 |
2020-07-07 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
DK2563776T3
(en)
|
2010-04-27 |
2016-09-19 |
Calcimedica Inc |
Relations that modulate intracellular calcium
|
|
AU2011248579A1
(en)
|
2010-04-27 |
2012-11-29 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
EP2609095A4
(en)
|
2010-08-27 |
2014-06-18 |
Calcimedica Inc |
COMPOUNDS MODULATING INTRACELLULAR CALCIUM
|
|
KR101840313B1
(ko)
*
|
2011-02-14 |
2018-03-21 |
에스에프씨 주식회사 |
피리딘 유도체 화합물 및 이를 포함하는 유기전계발광소자
|
|
US20120316182A1
(en)
|
2011-06-10 |
2012-12-13 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
US9856240B2
(en)
|
2011-10-19 |
2018-01-02 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
US8871778B2
(en)
*
|
2012-01-20 |
2014-10-28 |
Genosco |
Substituted pyrimidine compounds and their use as SYK inhibitors
|
|
WO2014059333A1
(en)
|
2012-10-12 |
2014-04-17 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
US8969365B2
(en)
|
2013-08-02 |
2015-03-03 |
Syntrix Biosystems, Inc. |
Thiopyrimidinecarboxamides as CXCR1/2 modulators
|
|
US10561676B2
(en)
|
2013-08-02 |
2020-02-18 |
Syntrix Biosystems Inc. |
Method for treating cancer using dual antagonists of CXCR1 and CXCR2
|
|
US10046002B2
(en)
|
2013-08-02 |
2018-08-14 |
Syntrix Biosystems Inc. |
Method for treating cancer using chemokine antagonists
|
|
ES3033759T3
(en)
|
2015-02-27 |
2025-08-07 |
Calcimedica Inc |
Pancreatitis treatment
|
|
CA2995094A1
(en)
|
2015-08-07 |
2017-02-16 |
Calcimedica, Inc. |
Use of crac channel inhibitors for the treatment of stroke and traumatic brain injury
|
|
WO2019028171A1
(en)
|
2017-08-01 |
2019-02-07 |
Ptc Therapeutics, Inc. |
DHODH INHIBITOR FOR USE IN THE TREATMENT OF HEMATOLOGICAL CANCERS
|
|
US11117893B2
(en)
*
|
2018-09-24 |
2021-09-14 |
Union University |
Methods for preparation of substituted pyridines and related novel compounds
|
|
CA3172249A1
(en)
|
2020-03-20 |
2021-09-23 |
Calcimedica, Inc. |
Methods and compositions for treating acute lung injury and acute respiratory distress syndrome
|
|
CA3198798A1
(en)
|
2020-11-13 |
2022-05-19 |
Kenneth Stauderman |
Improved synthesis of crac channel inhibitors
|